Open AccessHigh indinavir plasma concentrations in HIV-positive patients co-infected with hepatitis B or C virus treated with low doses of indinavir and ritonavir (400/100 mg twice a day) plus two nucleoside reverse transcriptase inhibitors
Author(s) -
Philippe Bossi,
Gilles Peytavin,
C. Lamotte,
Vincent Cálvez,
François Bricaire,
Dominique Costagliola,
Christine Katlama
Publication year - 2003
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/00002030-200305020-00030
Subject(s) - indinavir , ritonavir , medicine , cmin , regimen , gastroenterology , viral load , reverse transcriptase inhibitor , hepatitis c , hepatitis c virus , context (archaeology) , virology , pharmacology , pharmacokinetics , virus , biology , cmax , antiretroviral therapy , paleontology